Tower Research Capital LLC (Trc) Immunome Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Immunome Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,001 shares of IMNM stock, worth $119,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,001
Previous 6,938
0.91%
Holding current value
$119,997
Previous $64,000
26.56%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IMNM
# of Institutions
166Shares Held
71.5MCall Options Held
325KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.42MShares$144 Million0.06% of portfolio
-
Redmile Group, LLC San Francisco, CA5.02MShares$86.1 Million6.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$83.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.82MShares$82.7 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$69.9 Million3.55% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $208M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...